Company Directory / Alternative Medicine
PrivateFor profitAlternative MedicineNew York, United States
Orbital Therapeutics
Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.
- Founded
- 2022 4 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $270M as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
4 years old.
Reach
Website ranked #9,927,671 in the world for traffic, about 288 visits a month.
What it does
Alternative MedicineBiotechnologyLife ScienceTherapeutics
Funding, as listed
$270M currency not stated
- Rounds2
- LatestSeries a, Apr 2023
- Investors14, 1 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Orbital Therapeutics, field by field. Contact details are held but never shown.
The company
- Name
- Orbital Therapeutics
- Type
- For profit
- Status
- Private
- Founded
- 2022
- Founders
- Carol Suh, Drew Weissman, Ph.D, Gene Yeo, Giuseppe Ciaramella, Howard Chang, John Maraganore, Kristina Burow, Ravi Majeti
- Industry
- Alternative Medicine
- Categories
- Alternative Medicine, Biotechnology, Life Science, Therapeutics
Where
- City
- New York
- Country
- United States
- Markets
- Greater Boston Area, East Coast, New England, Northeastern US
Size and reach
- Staff band
- 11-50
- Web traffic rank
- #9,927,671
- Monthly web visits
- 288
Funding, as listed
- Total
- 270,000,000 (currency not stated)
- Rounds
- 2
- Latest round
- Series a
- Latest round date
- Apr 2023
- Investors
- 14
- Lead investors
- 1
- Listing status
- private
About this record
- Sources
- crunchbase,site-facts
- Last imported
- Sept 2026
Growth, as the source summarises it
Orbital Therapeutics may be growing as it has successfully secured over $250 million in funding, which is a significant financial boost that can support research, development, and expansion efforts. The company has also expanded its operational footprint by subleasing a 166,000-square-foot facility at 100 Binney St., indicating an increase in its physical capacity to accommodate growth. This expansion into a larger space suggests that Orbital Therapeutics is scaling up its operations, which is typically a sign of a company's growth and development within the biotechnology industry.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
Alternative Medicine in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.